The Latest Breaking News from Mobile X Global Inc

 Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 600 points on Monday.

Industrial monitoring systems firm Electro-Sensors, Inc (NASDAQ:ELSE) and Mobile X Global, Inc, a connectivity-as-a-service company, agreed to merge and re-name the combined company Mobile X Global, Inc. Mobile X Global, Inc will launch Mobile X, a new wireless brand positioned to disrupt the wireless industry.  Shares of the company will likely trade on the…